Tenaya Therapeutics, Inc. (TNYA)
$0.52-8.77%Close
SELLCRISIS · day 14
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $87M
- Beta
- 2.88
- P/E (TTM)
- -0.98
- Short % float
- 14.67%
- Days to cover
- 7.5
- SI change
- +5.9%
- 1W
- -5.45%
- 1M
- -24.64%
- vs SPY 1W
- -5.32%
- vs SPY 1M
- -27.14%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on TNYA?
- LOPJLB’s latest quantitative signal on Tenaya Therapeutics, Inc. (TNYA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is TNYA in?
- Tenaya Therapeutics, Inc. (TNYA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Tenaya Therapeutics, Inc. (TNYA) do?
- Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in Phase 1b/2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventric…